| Anaemia | Blood and lymphatic system disorders | MedDRA | Non-systematic Assessment | | - EG00012 affected943 at risk
- EG0018 affected929 at risk
|
| Haemolytic anaemia | Blood and lymphatic system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Iron deficiency anaemia | Blood and lymphatic system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Pernicious anaemia | Blood and lymphatic system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| AV dissociation | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Acute coronary syndrome | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Acute myocardial infarction | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Angina pectoris | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0018 affected929 at risk
|
| Aortic valve disease mixed | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Aortic valve incompetence | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Aortic valve stenosis | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG00069 affected943 at risk
- EG00160 affected929 at risk
|
| Arrhythmia | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0012 affected929 at risk
|
| Arteriosclerosis coronary artery | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG00045 affected943 at risk
- EG00127 affected929 at risk
|
| Atrial flutter | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0008 affected943 at risk
- EG0011 affected929 at risk
|
| Atrial tachycardia | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Atrial thrombosis | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Atrioventricular block | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0012 affected929 at risk
|
| Atrioventricular block complete | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0006 affected943 at risk
- EG0015 affected929 at risk
|
| Atrioventricular block second degree | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0013 affected929 at risk
|
| Bradyarrhythmia | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Bradycardia | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Cardiac amyloidosis | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Cardiac arrest | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Cardiac disorder | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Cardiac failure | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0005 affected943 at risk
- EG0016 affected929 at risk
|
| Cardiac failure acute | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Cardiac failure congestive | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Cardiac tamponade | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Cardiovascular disorder | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Coronary artery disease | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0015 affected929 at risk
|
| Coronary artery stenosis | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Dressler's syndrome | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Extrasystoles | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Hypertrophic cardiomyopathy | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Myocardial infarction | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0007 affected943 at risk
- EG0017 affected929 at risk
|
| Myocardial ischaemia | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0010 affected929 at risk
|
| Myocarditis | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Nodal arrhythmia | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Palpitations | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0013 affected929 at risk
|
| Pericardial effusion | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0005 affected943 at risk
- EG0017 affected929 at risk
|
| Pericardial haemorrhage | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Sick sinus syndrome | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0004 affected943 at risk
- EG0016 affected929 at risk
|
| Silent myocardial infarction | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Sinoatrial block | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Supraventricular tachycardia | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Tachyarrhythmia | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Tachycardia | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Tachycardia paroxysmal | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Ventricular arrhythmia | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Ventricular extrasystoles | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Ventricular fibrillation | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0011 affected929 at risk
|
| Ventricular tachycardia | Cardiac disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Dermoid cyst | Congenital, familial and genetic disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Gastrointestinal angiodysplasia | Congenital, familial and genetic disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Gastrointestinal angiodysplasia haemorrhagic | Congenital, familial and genetic disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Hydrocele | Congenital, familial and genetic disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Phimosis | Congenital, familial and genetic disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Deafness neurosensory | Ear and labyrinth disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Deafness unilateral | Ear and labyrinth disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Vertigo | Ear and labyrinth disorders | MedDRA | Non-systematic Assessment | | - EG0006 affected943 at risk
- EG0017 affected929 at risk
|
| Goitre | Endocrine disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Hyperthyroidism | Endocrine disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Amaurosis fugax | Eye disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Cataract | Eye disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0016 affected929 at risk
|
| Dacryostenosis acquired | Eye disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Diplopia | Eye disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Eye haemorrhage | Eye disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Glaucoma | Eye disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0013 affected929 at risk
|
| Retinal artery occlusion | Eye disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0011 affected929 at risk
|
| Retinal detachment | Eye disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0012 affected929 at risk
|
| Vitreous haemorrhage | Eye disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Abdominal discomfort | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Abdominal hernia | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Abdominal pain | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0009 affected943 at risk
- EG0015 affected929 at risk
|
| Abdominal pain upper | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0013 affected929 at risk
|
| Anal polyp | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Anal stenosis | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Appendicitis perforated | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Colitis ischaemic | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Colonic obstruction | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0012 affected929 at risk
|
| Crohn's disease | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Diarrhoea | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Diverticulum | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Diverticulum intestinal haemorrhagic | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Duodenal ulcer | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0013 affected929 at risk
|
| Duodenal ulcer haemorrhage | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Dyspepsia | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Dysphagia | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Faecal incontinence | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Gastric haemorrhage | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Gastric ulcer | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0007 affected943 at risk
- EG0012 affected929 at risk
|
| Gastric ulcer haemorrhage | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Gastritis | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0013 affected929 at risk
|
| Gastrooesophageal reflux disease | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Haematemesis | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Haemorrhoidal haemorrhage | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Haemorrhoids | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Heyde's syndrome | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Hiatus hernia | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Ileus | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Ileus paralytic | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Inguinal hernia | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG00015 affected943 at risk
- EG00115 affected929 at risk
|
| Intestinal ulcer | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Large intestinal ulcer | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Mechanical ileus | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Mesenteric vein thrombosis | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Mouth haemorrhage | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Nausea | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0015 affected929 at risk
|
| Necrotising oesophagitis | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Oesophagitis | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Pancreatitis | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Pancreatitis acute | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Peptic ulcer | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Peritonitis | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Rectal haemorrhage | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0004 affected943 at risk
- EG0011 affected929 at risk
|
| Reflux oesophagitis | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Retroperitoneal haematoma | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Retroperitoneal haemorrhage | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Umbilical hernia | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Vomiting | Gastrointestinal disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Alanine aminotransferase increased | General disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Aspartate aminotransferase increased | General disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0010 affected929 at risk
|
| Blood creatine phosphokinase increased | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Blood creatinine increased | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Blood potassium increased | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Blood sodium decreased | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Blood urine present | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| C-reactive protein increased | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Cardiac output decreased | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Ejection fraction decreased | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Electrocardiogram abnormal | General disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Haemoglobin decreased | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| International normalised ratio | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| International normalised ratio decreased | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| International normalised ratio increased | General disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0014 affected929 at risk
|
| Occult blood positive | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Platelet count decreased | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Prostatic specific antigen increased | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Pulmonary function test decreased | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Total lung capacity decreased | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Weight decreased | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Adverse drug reaction | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Asthenia | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Atrophy | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Catheter related complication | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Catheter site haemorrhage | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Chest discomfort | General disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Chest pain | General disorders | MedDRA | Non-systematic Assessment | | - EG00021 affected943 at risk
- EG00115 affected929 at risk
|
| Death | General disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0013 affected929 at risk
|
| Drowning | General disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Fatigue | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| General physical health deterioration | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Hernia | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Impaired healing | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Inflammation | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Malaise | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Mechanical complication of implant | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Multi-organ failure | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0013 affected929 at risk
|
| Necrosis | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Non-cardiac chest pain | General disorders | MedDRA | Non-systematic Assessment | | - EG0005 affected943 at risk
- EG0013 affected929 at risk
|
| Oedema peripheral | General disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Pain | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Pyrexia | General disorders | MedDRA | Non-systematic Assessment | | - EG0006 affected943 at risk
- EG0012 affected929 at risk
|
| Sudden cardiac death | General disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Sudden death | General disorders | MedDRA | Non-systematic Assessment | | - EG0007 affected943 at risk
- EG0016 affected929 at risk
|
| Ulcer | General disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Cholangitis | Hepatobiliary disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Cholecystitis | Hepatobiliary disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0013 affected929 at risk
|
| Cholecystitis acute | Hepatobiliary disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0014 affected929 at risk
|
| Gallbladder pain | Hepatobiliary disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Hepatic cirrhosis | Hepatobiliary disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Hepatic failure | Hepatobiliary disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Jaundice | Hepatobiliary disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Anaphylactic reaction | Immune system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Corneal graft rejection | Immune system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Secondary immunodeficiency | Immune system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Anal abscess | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Appendicitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Arthritis bacterial | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Arthritis infective | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Bronchitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Bronchopneumonia | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0011 affected929 at risk
|
| Cellulitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Chronic sinusitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Chronic tonsillitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Clostridium difficile colitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0010 affected929 at risk
|
| Cystitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Diverticulitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0014 affected929 at risk
|
| Endocarditis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0007 affected943 at risk
- EG00111 affected929 at risk
|
| Endocarditis bacterial | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Enterococcal sepsis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Erysipelas | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0016 affected929 at risk
|
| Febrile infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Fungal infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Gangrene | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Gastroenteritis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0007 affected943 at risk
- EG0011 affected929 at risk
|
| Groin abscess | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Haematoma infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Herpes zoster | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0013 affected929 at risk
|
| Influenza | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Intestinal gangrene | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Klebsiella sepsis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Laryngitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Localised infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Lower respiratory tract infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0013 affected929 at risk
|
| Lung infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Mastoiditis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Mediastinitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Meningitis pneumococcal | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Nasopharyngitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Neuroborreliosis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Orchitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Peritonsillitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Pneumonia | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG00028 affected943 at risk
- EG00131 affected929 at risk
|
| Pneumonia bacterial | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Pneumonia streptococcal | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Post procedural infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0012 affected929 at risk
|
| Postoperative wound infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Pseudomonas infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Pyelonephritis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Pyelonephritis acute | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Pyothorax | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Rash pustular | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Respiratory tract infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Sepsis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0006 affected943 at risk
- EG0016 affected929 at risk
|
| Sinusitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Skin infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Staphylococcal infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Staphylococcal sepsis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Sternitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Streptococcal sepsis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Subcutaneous abscess | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Tooth abscess | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Tracheobronchitis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Upper respiratory tract infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG00010 affected943 at risk
- EG00113 affected929 at risk
|
| Urosepsis | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Viral infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0011 affected929 at risk
|
| Wound infection | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Wound infection staphylococcal | Infections and infestations | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Alcohol poisoning | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Ankle fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Arthropod bite | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Asbestosis | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Cardiac pacemaker malfunction | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Cerebral haemorrhage traumatic | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Chest injury | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Clavicle fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Concussion | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Contusion | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Device failure | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Device occlusion | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Dislocation of joint prosthesis | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Drug administration error | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Drug toxicity | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Facial bones fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0007 affected943 at risk
- EG0013 affected929 at risk
|
| Femoral neck fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0015 affected929 at risk
|
| Femur fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0016 affected929 at risk
|
| Gastrointestinal stoma complication | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Hand fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Head injury | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Hip fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0004 affected943 at risk
- EG0014 affected929 at risk
|
| Humerus fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Incision site pain | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Incisional hernia | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Jaw fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Joint dislocation | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Lower limb fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Medical device complication | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Meniscus lesion | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0013 affected929 at risk
|
| Multiple fractures | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Open wound | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Operative haemorrhage | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Overdose | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Pelvic fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Post procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0014 affected929 at risk
|
| Postoperative constipation | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Postpericardiotomy syndrome | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Procedural pain | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Procedural site reaction | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Pubic rami fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Radius fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Renal haematoma | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Rib fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0013 affected929 at risk
|
| Road traffic accident | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Skin laceration | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Skull fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Snake bite | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Spinal fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Subdural haematoma | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Subdural haemorrhage | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Tendon rupture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Therapeutic agent toxicity | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Thermal burn | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Tibia fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Ulna fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Upper limb fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Vascular graft occlusion | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Wound dehiscence | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Wrist fracture | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Dehydration | Metabolism and nutrition disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Diabetes mellitus | Metabolism and nutrition disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Hyperkalaemia | Metabolism and nutrition disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Hyponatraemia | Metabolism and nutrition disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Podagra | Metabolism and nutrition disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0004 affected943 at risk
- EG0011 affected929 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0004 affected943 at risk
- EG0012 affected929 at risk
|
| Arthritis reactive | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Arthropathy | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0010 affected929 at risk
|
| Articular calcification | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0012 affected929 at risk
|
| Bursitis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| CREST syndrome | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Dupuytren's contracture | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Flank pain | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Foot deformity | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Gouty arthritis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Haemarthrosis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0004 affected943 at risk
- EG0010 affected929 at risk
|
| Joint ankylosis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Limb deformity | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Muscle haemorrhage | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Muscle necrosis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Musculoskeletal pain | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0012 affected929 at risk
|
| Myalgia | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Myalgia intercostal | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Myosclerosis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG00019 affected943 at risk
- EG00121 affected929 at risk
|
| Osteochondrosis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Osteolysis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Osteoporosis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Pain in jaw | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Periarthritis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Polyarthritis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Pseudarthrosis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Rotator cuff syndrome | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0013 affected929 at risk
|
| Spinal column stenosis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0015 affected929 at risk
|
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Spondylolysis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Synovitis | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Systemic lupus erythematosus | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Abdominal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0013 affected929 at risk
|
| Adenocarcinoma pancreas | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| B-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0009 affected943 at risk
- EG0014 affected929 at risk
|
| Benign neoplasm of thyroid gland | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Benign renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Bladder cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0014 affected929 at risk
|
| Bladder neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Bladder transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Bone neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Bowen's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Brain neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Breast cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0008 affected943 at risk
- EG0012 affected929 at risk
|
| Breast cancer female | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Breast cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Bronchial carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Burkitt's lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Cancer pain | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Carcinoid tumour pulmonary | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Carcinoma in situ | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Cerebellar tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Cholesteatoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Colon cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0014 affected929 at risk
|
| Colon cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Fibroma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Glioblastoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Hepatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Hepatic neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Hodgkin's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Lip neoplasm malignant stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Lung adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Lung adenocarcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0013 affected929 at risk
|
| Lung neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0004 affected943 at risk
- EG0012 affected929 at risk
|
| Lung squamous cell carcinoma stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Lymphocytic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0012 affected929 at risk
|
| Meningioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Metastases to bladder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Metastases to bone | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Metastases to gallbladder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Metastases to liver | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Metastases to spine | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Metastatic carcinoma of the bladder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Metastatic malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Metastatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Myeloproliferative disorder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Non-Hodgkin's lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Non-Hodgkin's lymphoma recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Oesophageal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Ovarian cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0013 affected929 at risk
|
| Pancreatic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Pelvic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Plasmacytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG00021 affected943 at risk
- EG00114 affected929 at risk
|
| Prostate cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Prostate cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Rectal adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Rectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0013 affected929 at risk
|
| Rectal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Renal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Renal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Skin cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0004 affected943 at risk
- EG0011 affected929 at risk
|
| T-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Tumour haemorrhage | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Ureteric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Uterine cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Uterine leiomyoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Vulval cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Amyotrophic lateral sclerosis | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Balance disorder | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Carotid artery stenosis | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Carotid sinus syndrome | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Cerebral infarction | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Cerebrovascular accident | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0014 affected929 at risk
|
| Cognitive disorder | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Convulsion | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0012 affected929 at risk
|
| Dementia | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Dementia Alzheimer's type | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Dizziness | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0007 affected943 at risk
- EG0013 affected929 at risk
|
| Encephalitis | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Epilepsy | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0007 affected943 at risk
- EG0012 affected929 at risk
|
| Facial palsy | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Global amnesia | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Haemorrhagic stroke | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Headache | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Hemiparesis | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Hypoaesthesia | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Intracranial aneurysm | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Motor neurone disease | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Narcolepsy | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Presyncope | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0015 affected929 at risk
|
| Radicular syndrome | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Senile dementia | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Somnolence | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Spinal cord compression | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Subarachnoid haemorrhage | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Subdural hygroma | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Syncope | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG00014 affected943 at risk
- EG00119 affected929 at risk
|
| Syncope vasovagal | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Transient ischaemic attack | Nervous system disorders | MedDRA | Non-systematic Assessment | | - EG00011 affected943 at risk
- EG00111 affected929 at risk
|
| Anxiety | Psychiatric disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Completed suicide | Psychiatric disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Confusional state | Psychiatric disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0010 affected929 at risk
|
| Delusional disorder, persecutory type | Psychiatric disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Depression | Psychiatric disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0012 affected929 at risk
|
| Major depression | Psychiatric disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Mental disorder | Psychiatric disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Mental disorder due to a general medical condition | Psychiatric disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Panic attack | Psychiatric disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Psychosomatic disease | Psychiatric disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Anuria | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Azotaemia | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Bladder obstruction | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Calculus bladder | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Calculus urinary | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0012 affected929 at risk
|
| Haematuria | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0013 affected929 at risk
|
| Hydronephrosis | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Nephritis interstitial | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0011 affected929 at risk
|
| Renal artery arteriosclerosis | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Renal failure | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0015 affected929 at risk
|
| Renal failure acute | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Renal impairment | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Urethral meatus stenosis | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Urethral stenosis | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Urinary bladder polyp | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Urinary incontinence | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Urinary retention | Renal and urinary disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0014 affected929 at risk
|
| Acquired hydrocele | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Bartholinitis | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Benign prostatic hyperplasia | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0019 affected929 at risk
|
| Cystocele | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Endometrial hyperplasia | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Epididymitis | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Haemorrhagic ovarian cyst | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Ovarian cyst | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Pelvic pain | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Postmenopausal haemorrhage | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Prostatism | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Prostatomegaly | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Spermatocele | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Uterine malposition | Reproductive system and breast disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Bronchitis chronic | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Cheyne-Stokes respiration | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0015 affected929 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG00012 affected943 at risk
- EG00112 affected929 at risk
|
| Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Eosinophilic pneumonia chronic | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0009 affected943 at risk
- EG0011 affected929 at risk
|
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Laryngeal oedema | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Lung infiltration | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Nasal polyps | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Nasal septum deviation | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0009 affected943 at risk
- EG0017 affected929 at risk
|
| Pleurisy | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0010 affected929 at risk
|
| Pulmonary congestion | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0010 affected929 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0014 affected929 at risk
|
| Pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Pulmonary hypertension | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0014 affected929 at risk
|
| Sleep apnoea syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Angioedema | Skin and subcutaneous tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Dermal cyst | Skin and subcutaneous tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Dermatitis | Skin and subcutaneous tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Dermatitis allergic | Skin and subcutaneous tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Eczema | Skin and subcutaneous tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Pemphigoid | Skin and subcutaneous tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Rash | Skin and subcutaneous tissue disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Skin ulcer | Skin and subcutaneous tissue disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0012 affected929 at risk
|
| Urticaria | Skin and subcutaneous tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Vasculitic rash | Skin and subcutaneous tissue disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Cardiac assistance device user | Social circumstances | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Angiodysplasia | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Aortic aneurysm | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0006 affected943 at risk
- EG0014 affected929 at risk
|
| Aortic dissection | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Aortic rupture | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Arteriovenous fistula | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Bleeding varicose vein | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Circulatory collapse | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Deep vein thrombosis | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0012 affected929 at risk
|
| Femoral artery aneurysm | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Haematoma | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0003 affected943 at risk
- EG0013 affected929 at risk
|
| Haemorrhage | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0004 affected943 at risk
- EG0011 affected929 at risk
|
| Hypertension | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0013 affected929 at risk
|
| Hypertensive crisis | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0012 affected929 at risk
|
| Hypotension | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Intermittent claudication | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0013 affected929 at risk
|
| Orthostatic hypotension | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0010 affected929 at risk
|
| Peripheral arterial occlusive disease | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Phlebitis superficial | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Raynaud's phenomenon | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Shock | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Shock haemorrhagic | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|
| Thrombophlebitis | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0011 affected929 at risk
|
| Varicose vein | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Vascular occlusion | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Vascular pseudoaneurysm | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0012 affected929 at risk
|
| Venous stasis | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0000 affected943 at risk
- EG0011 affected929 at risk
|
| Venous thrombosis | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0002 affected943 at risk
- EG0011 affected929 at risk
|
| Venous thrombosis limb | Vascular disorders | MedDRA | Non-systematic Assessment | | - EG0001 affected943 at risk
- EG0010 affected929 at risk
|